ABOUT THIS EVENT

Legend Biotech Corporation (Nasdaq: LEGN), a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, rang the Nasdaq Closing Bell remotely from across the world. 

Yuan Xu, PhD, Chief Executive Officer, rang the Closing Bell alongside employees from around the world in a virtual bell ringing ceremony.